The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2024 | Advances in the diagnosis of AL amyloidosis: AmyLite diagnostic assay
In this video, Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, shares insights into a novel diagnostic assay known as AmyLite™, which is being explored to improve diagnosis in patients with light chain (AL) amyloidosis. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Research Support/P.I. Celgene, Millennium-Takeda, Janssen, Prothena, Sorrento, Karyopharm, Oncopeptide, Caelum, Alexion
Consultant Pfizer, Janssen, Attralus, GateBio, Abbvie
Scientific Advisory Board Proclara, Caelum, Abbvie, Janssen, Regeneron, Protego, Pharmatrace, Telix, Prothena, AstraZeneca, Nexcella
